Stephane Bancel Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephane Bancel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephane Bancel. Stephane Bancel is a Director in Targanta Therapeutics Corp. ($TARG) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and an Chief Executive Officer in Moderna, Inc. ($MRNA).
Address: C/O TARGANTA THERAPEUTICS CORP. 222 THIRD STREET CAMBRIDGE 02142 MA
Companies in which Stephane Bancel is an Insider
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stephane Bancel: Chief Executive Officer
Holdings: 19,458 shares
Latest Transaction: May 25 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephane Bancel: Director
Holdings: 47,980 shares
Current Value: $523,942
Latest Transaction: Sep 19 2016
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Targanta Therapeutics Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephane Bancel: Director
Holdings: 0 shares
Latest Transaction: Aug 26 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stephane Bancel
Sentiment: All, MRNA, SYRS, TARG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 168.49 | 500 | 84,245 | 11,062 | 11.6 K to 11.1 K (-4.32 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 167.39 | 887 | 148,475 | 11,562 | 12.4 K to 11.6 K (-7.13 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 166.37 | 1,159 | 192,823 | 12,449 | 13.6 K to 12.4 K (-8.52 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 165.46 | 600 | 99,276 | 13,608 | 14.2 K to 13.6 K (-4.22 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 164.15 | 1,100 | 180,565 | 14,208 | 15.3 K to 14.2 K (-7.19 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 163.09 | 4,150 | 676,824 | 15,308 | 19.5 K to 15.3 K (-21.33 %) |
| May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 162.30 | 2,650 | 430,095 | 19,458 | 22.1 K to 19.5 K (-11.99 %) |